[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366671-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366671-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","gastric-microbiome-in-gastric-cancer-sequence-depicts-diverse-microbial-structures-associated-with-cancer-risk-and-prognosis","Gastric microbiome in gastric cancer - sequence depicts diverse microbial structures associated with cancer risk and prognosis","","Objective Increasing evidence indicates non-Helicobacter pylori microbiota substantially contributes to gastric tumorigenesis. This study delineates microbiome dynamics across two gastric cancer stages—initiation and progression—and evaluates links to clinicopathological and molecular alterations. Methods Gastric microbiomes were characterized at initiation and progression using 944 biopsies from primary gastric cancer, non-cancerous mucosa from cancer patients, and non-cancer subjects. Microbial characteristics were tested for associations with cancer risk, prognosis, and molecular changes including TP53 mutation, DNA methylation, and telomere shortening. Results α-diversity decreased with cancer occurrence yet increased in primary tumor tissue; similar paradoxes appeared within specific bacterial groups. Risk-related microbiomes associated with differentiated gastric cancer, severe intestinal metaplasia, DNA methylation, and telomere shortening, whereas tumor tissue-specific microbiomes associated with aggressive features and TP53 status. Conclusions Non-Helicobacter pylori microbiota plays distinct roles in initiation versus progression of gastric cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/gastric-microbiome-in-gastric-cancer-sequence-depicts-diverse-microbial-structures-associated-with-cancer-risk-and-prognosis/366671/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/gastric-microbiome-in-gastric-cancer-sequence-depicts-diverse-microbial-structures-associated-with-cancer-risk-and-prognosis/366671.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main objective regarding the gastric microbiome?","Question",{"text":63,"@type":64},"To clarify how non-Helicobacter pylori microbiome dynamics differ between gastric cancer initiation and progression and how they relate to clinical, pathological, and molecular changes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were gastric microbiomes characterized in this research?",{"text":68,"@type":64},"Using 944 biopsies covering primary gastric cancer tissue and non-cancerous mucosa from both cancer and non-cancer subjects, followed by evaluation of links to risk, prognosis, and molecular markers.",{"name":70,"@type":61,"acceptedAnswer":71},"Which molecular and clinical features were associated with microbiome patterns?",{"text":72,"@type":64},"Risk-related microbiomes linked with differentiated cancer, severe intestinal metaplasia, associated DNA methylation, and telomere shortening, while tumor-specific microbiomes linked with aggressive features and TP53 mutation status.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366671,1790197800,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Shimogama etal. Journal of Translational Medicine (2025) 23:1039  \n[https://doi.org/10.1186/s12967-025-07046-5](https://doi.org/10.1186/s12967-025-07046-5)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nGastric microbiome in gastric cancer   \nsequence depicts diverse microbial structures associated with cancer risk and prognosis  \nTsubasa Shimogama 1, Tomomitsu Tahara 1*, Takuya Shijimaya 1, Jumpei Yamazaki2,3, Sanshiro Kobayashi 1,  \nNaohiro Nakamura 1, Yu Takahashi 1, Takashi Tomiyama 1, Yusuke Honzawa 1, Toshiro Fukui 1 and Makoto Naganuma  \nAbstract  \nObjective Increasing evidence indicated substantial involvement of non-Helicobacter pylori microbiota in gastric tumorigenesis. We aimed to elucidate detailed relationship of microbiome dynamics between two different steps in gastric cancer (GC) such as cancer initiation and progression, and assessed their associations with clinicopathological and molecular changes.  \nMethods We systemically characterized gastric microbiome during GC initiation and progression using 944 biopsies from primary GC, non-cancerous gastric mucosa from both GC and non-cancer subjects. The association between specific microbial characteristics and GC risk, prognosis and molecular changes such as TP53 mutation, DNA methylation and telomere shortening were also evaluated.  \nResults Microbial α-diversity in the gastric mucosa was decreased in relation to the GC occurrence, while it increased in primary GC tissue. Such paradoxical change was also observed in specific groups of bacteria during GC occurrence and its progression. GC risk-related microbiome was associated with differentiated GC, severe intestinal metaplasia, associated DNA methylation and telomere shortening, while GC tissue-specific microbiome was associated with more aggressive features of GC and TP53 mutation status.  \nConclusions Our findings suggested the different role of non-Helicobacter pylori microbiota in GC initiation and progression steps.  \nKeywords Gastric cancer, Microbiota, DNA methylation, Risk, Prognosis  \n*Correspondence:  \nTomomitsu Tahara  \n[tahara.tom@kmu.ac.jp](tahara.tom@kmu.ac.jp)  \n1Third Department of Internal Medicine, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, Japan  \n2Translational Research Unit, Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan  \n3One Health Research Center, Hokkaido University, Sapporo, Japan  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nShimogama et al. Journal of Translational Medicine (2025) 23:1039  \nIntroduction  \nGastric cancer (GC) is ranked fifth regarding the incidence rate among human malignancies and ranks fourth in mortality [1]. Despite advance in strategy for early detection, many patients still have advanced disease at diagnosis. Since the prognosis of patients with advanced tumor is poor [2, 3], deeper understanding of the pathogenesis that drives the transition from nor","cbCaikbS62fC3AgA","https://ap.wps.com/l/cbCaikbS62fC3AgA","pdf",3533856,13,"English","# Abstract\n# Introduction","[{\"question\":\"What is the study’s main objective regarding the gastric microbiome?\",\"answer\":\"To clarify how non-Helicobacter pylori microbiome dynamics differ between gastric cancer initiation and progression and how they relate to clinical, pathological, and molecular changes.\"},{\"question\":\"How were gastric microbiomes characterized in this research?\",\"answer\":\"Using 944 biopsies covering primary gastric cancer tissue and non-cancerous mucosa from both cancer and non-cancer subjects, followed by evaluation of links to risk, prognosis, and molecular markers.\"},{\"question\":\"Which molecular and clinical features were associated with microbiome patterns?\",\"answer\":\"Risk-related microbiomes linked with differentiated cancer, severe intestinal metaplasia, associated DNA methylation, and telomere shortening, while tumor-specific microbiomes linked with aggressive features and TP53 mutation status.\"}]","Gastric microbiome in gastric cancer - sequence depicts diverse microbial structures associated with cancer risk and prognosis | PDF",1790166647,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45ade3abf52ad52ddf99040833b00c1b.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf2e99f0a1046f906d03104c77b28027.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b938958e60bf248a62904a45cd998999.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6cc7125f7a79d94efa3fab411ec472f.webp",980,1306]